During the last session, Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares were 0.49 million, with the beta value of the company hitting 1.02. At the end of the trading day, the stock’s price was $1.82, reflecting an intraday gain of 2.25% or $0.04. The 52-week high for the QNCX share is $2.45, that puts it down -34.62 from that peak though still a striking 71.98% gain since the share price plummeted to a 52-week low of $0.51. The company’s market capitalization is $82.75M, and the average intraday trading volume over the past 10 days was 0.29 million shares, and the average trade volume was 365.60K shares over the past three months.
Quince Therapeutics Inc (NASDAQ:QNCX) trade information
Quince Therapeutics Inc (QNCX) registered a 2.25% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.25% in intraday trading to $1.82, hitting a weekly high. The stock’s 5-day price performance is 13.04%, and it has moved by 51.67% in 30 days. Based on these gigs, the overall price performance for the year is -2.67%. The short interest in Quince Therapeutics Inc (NASDAQ:QNCX) is 0.47 million shares and it means that shorts have 1.57 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 7.53%. While earnings are projected to return 25.95% in 2025, the next five years will return 25.46% per annum.
QNCX Dividends
Quince Therapeutics Inc is due to release its next quarterly earnings on 2025-May-13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Quince Therapeutics Inc (NASDAQ:QNCX)’s Major holders
Quince Therapeutics Inc insiders own 13.14% of total outstanding shares while institutional holders control 22.25%, with the float percentage being 25.62%.
Also, the Mutual Funds coming in first place with the largest holdings of Quince Therapeutics Inc (QNCX) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 861.39 shares. This amounts to just over 1.89 percent of the company’s overall shares, with a $1.57 million market value. The same data shows that the other fund manager holds slightly less at 418.22, or about 0.92% of the stock, which is worth about $0.76 million.
